Arthrosi Therapeutics Funding: $75M Raised, Series D (2025)
Arthrosi Therapeutics is based in San Diego. It has raised $75M in total funding. Latest round: Series D.
Arthrosi Therapeutics funding overview
Arthrosi Therapeutics is based in San Diego. Arthrosi Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in October 2025. The round record for Arthrosi Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Guangrun Health Industry (Hong Kong) Co. Limited, Reichstein Biotech (HK) Co. Limited. 2 distinct backers are named across the disclosed rounds.
Arthrosi Therapeutics at a glance
Total raised
$75M
Latest round
Series D
Latest round date
October 2025
Headquarters
San Diego
Notable investors
Guangrun Health Industry (Hong Kong) Co. Limited, Reichstein Biotech (HK) Co. Limited
Frequently asked about Arthrosi Therapeutics funding
How much has Arthrosi Therapeutics raised?
Arthrosi Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Arthrosi Therapeutics?
Guangrun Health Industry (Hong Kong) Co. Limited, Reichstein Biotech (HK) Co. Limited are named among the investors backing Arthrosi Therapeutics.
What was the latest Arthrosi Therapeutics funding round?
The most recent disclosed round is a Series D, announced in October 2025.
Where is Arthrosi Therapeutics based?
Arthrosi Therapeutics is based in San Diego.
When did Arthrosi Therapeutics last raise?
The last disclosed Arthrosi Therapeutics round closed in October 2025 at Series D.
Every Arthrosi Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
